We've upgraded AI Search on TaxTMI with two powerful modes:
1. Basic • Quick overview summary answering your query with references• Category-wise results to explore all relevant documents on TaxTMI
2. Advanced • Includes everything in Basic • Detailed report covering: - Overview Summary - Governing Provisions [Acts, Notifications, Circulars] - Relevant Case Laws - Tariff / Classification / HSN - Expert views from TaxTMI - Practical Guidance with immediate steps and dispute strategy
• Also highlights how each document is relevant to your query, helping you quickly understand key insights without reading the full text.Help Us Improve - by giving the rating with each AI Result:
Assessee deemed real manufacturer despite outsourcing production, qualifies as industrial company and retains concessional tax benefits HC upheld the Appellate Tribunal's finding that the assessee qualified as an 'industrial company' for the relevant assessment year. Although the assessee ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Assessee deemed real manufacturer despite outsourcing production, qualifies as industrial company and retains concessional tax benefits
HC upheld the Appellate Tribunal's finding that the assessee qualified as an "industrial company" for the relevant assessment year. Although the assessee had transferred its plant and machinery to an associated pharmaceutical concern and thereafter got its products manufactured through that concern, the HC held the assessee remained the real manufacturer because it retained control over the manufacturing process and caused the goods to be produced through another's agency. Direct engagement or payment of workers' wages was not essential to manufacturer status. Both reference questions were answered in the affirmative, in favour of the assessee, confirming concessional tax treatment.
Issues involved: Determination of whether the assessee was a manufacturer of the articles in question and whether the assessee could be treated as an 'industrial company' for tax purposes.
Manufacturing Activity Analysis: The assessee initially manufactured pharmaceutical goods with its own plant and machinery, later transferring them to an associate company for manufacturing. Subsequently, the assessee resumed manufacturing with its own facilities during the relevant assessment year. The assessee maintained control over the manufacturing process, including quality control, when utilizing the services of the associate company. The court emphasized that the assessee's engagement in manufacturing activities was evident.
Legal Precedents and Interpretation: Referring to the case of CIT v. Neo Pharma Private Ltd., the court highlighted that a company could be considered engaged in manufacturing goods even if it utilized another company for manufacturing under its supervision or control. The court noted that direct supervision by the assessee over the manufacturing process was not a strict requirement for classification as a manufacturing company.
Judgment and Conclusion: The court agreed with the Tribunal's view that the assessee qualified as an industrial company engaged in manufacturing activities. It was deemed sufficient that the assessee was the actual manufacturer, even if it did not directly supervise the manufacturing process or pay the workers' wages. Citing the precedent and factual analysis, the court answered both questions in the affirmative and in favor of the assessee, leading to a decision without costs.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.